Annual report pursuant to Section 13 and 15(d)

Consolidated Statements of Comprehensive Loss

v3.20.1
Consolidated Statements of Comprehensive Loss - USD ($)
$ in Thousands
12 Months Ended
Dec. 31, 2019
Dec. 31, 2018
Statement of Comprehensive Income [Abstract]    
Revenue $ 107 $ 36
Cost of revenue 136 54
Gross loss (29) (18)
Operating expenses:    
Research and development 9,013 6,048
Sales and marketing 4,897 4,312
General and administrative 9,497 8,547
Total operating expenses 23,407 18,907
Operating loss (23,436) (18,925)
Warrant expense (3,156)
Gain (loss) on change in estimated fair value of contingent royalty obligation 81 (291)
Finance income, net 273 103
Other income 38
Foreign currency loss (4) (26)
Loss before income taxes (23,086) (22,257)
Income tax expense
Net loss $ (23,086) $ (22,257)
Basic and diluted loss per common share $ (0.92) $ (1.47)
Weighted average number of common shares outstanding, basic and diluted 25,133,190 15,137,144